Answer: She should file an appeal of this initial determination within 120 days of the date that she got the Medicare Summary Notice in the mail
Explanation:
The Medicare Summary Notice refers to the notice that the individuals who have Original Medicare get in their mail for Medicare Part A and Part B-covered services.
Since Mrs Duarte disagrees with a determination that partially denied one of her claims for services, then she should file an appeal of the initial determination within 120 days of the date that she got the Medicare Summary Notice in the mail.
Answer:
coelomic cavity
Explanation:
the coelomic cavity acts as a transfer area as well as a reservoir of nutrients for the growing embryo.
Answer:
Explanation:
The average salary for a registered nurse is $32.46 per hour in Washington State and $13,625 overtime per year. Data source tooltip for additional compensation. Was the salaries overview information useful?
Answer: Blood loss regulation
Explanation:
Positive feed back is response of body in which there is an increase in the effect of small disturbance and the effect is intensified on a system. The magnitude of the effect increases.
In case of blood loss the body releases clotting factors that helps in preventing the body from severe blood loss.
The body releases clotting factors and these clotting factors tend to release more and more clotting factors that begins the process of blood clotting in vessels.
This is an example of positive feedback which acts as a life saving cascade.
According to a study, venetoclax plus hypomethylating agent is effective in newly diagnosed acute myeloid leukemia, and safe in an outpatient setting. So the statement is true.
<h3>What is venetoclax?</h3>
Venetoclax is either used alone or in combination with another drug called obinutuzumab or rituximab. This is used for the treatment of certain types of chronic lymphocytic leukemia. It is a type of cancer that develops in white blood cells. It is also used for certain types of small lymphocytic lymphoma, which is a type of cancer that develops in the lymph nodes.
It can also be used in combination with either azacitidine, decitabine, or cytarabine. This is done as the initial treatment for acute myeloid leukemia, which is a type of cancer that begins in the white blood cells in people who are 75 years or older. It can also develop in adults having medical conditions that prevent them from being treated with any other treatment than chemotherapy medications.
The class of medications from which Venetoclax belongs is called B-cell lymphoma-2 inhibitors. These medicines work by blocking the action of a particular protein in the body that promotes cancer cells' survival. This helps in killing cancer cells.
Therefore, the statement is true.
Read more about leukemia, here
brainly.com/question/5868856
#SPJ4
